Coagulation Factor VII, Dietary Fat and Blood Lipids: A Review^[*]

^* This work was supported by a grant from the Dutch Organization of Scientific Research (No. 904-61-076)

• References

• 1 Meade TW, Brozović M, Chakrabarti RR. et al Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. The Lancet 1986; 06: 533-537
• 2 Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Q J Med 1994; 87: 403-406
• 3 Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59
• 4 Miller GJ, Stirling Y, Esnouf MP. et al Factor VH-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48
• 5 Miller GJ, Martin JC, Mitropoulos KA. et al Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-71
• 6 Folsom AR, Wu KK, Shahar E, Davis CE. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829-36
• 7 Broadhurst P, Kelleher C, Hughes L, Imeson JD, Raftery EB. Fibrinogen factor VII clotting activity and coronary artery disease severity. Atherosclerosis 1990; 85: 169-73
• 8 Carvalho de Sousa J, Azevedo J, Soria C. Factor VII hyperactivation in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165-173
• 9 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 1989; 14: 941-946
• 10 Hoffman CJ, Bums P, Lawson WE, Katz JP, Miller RH, Hultin MB. Plasma fibrinogen level is not elevated in young adults from families with premature ischemic heart disease. Arterioscler Thromb 1993; 13: 800-3
• 11 Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-81
• 12 Suzuki T, Yamauchi K, Matsusita T. et al Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731-736
• 13 Wu KK, Folsom AR, Heiss G, Davisx CE, Conlan MG, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the atherosclerosis risk in communities (ARIC) study. Ann Epidemiol 1992; 4: 471-480
• 14 Sosef MN, Bosch JG, Oostayen Jvan, Visser T, Reiber JHC, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost 1994; 72: 250-254
• 15 Balleisen L, Bailey J, Epping PH, Schulte H, Loo Jvan de. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemost 1985; 54: 475-479
• 16 Miller GJ, Cruickshank JK, Ellis LJ. et al Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 1989; 78: 19-24
• 17 Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-233
• 18 Heinrich J, Wahrburg U, Marting H, Assmann G. The effect of diets, rich in mono-or polyunsaturated fatty acids, on lipid metabolism and haemostasis. Fibrinolysis 1990; 4: 76-78
• 19 Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol 1992; 4: 481-94
• 20 Bruckert E, Carvalho de Sousa J, Giral P. et al Interrelationships of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis 1989; 75: 129-34
• 21 Carvalho de Sous J, Bruckert E, Giral P. et al Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 1989; 19: 125-30
• 22 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546
• 23 Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity inethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
• 24 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198
• 25 Fuller JH, Keen H, Jarret RJ. et al Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 02: 964-6
• 26 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744
• 27 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemost 1992; 68: 301-305
• 28 Poggio M, Tripodi A, Mariani G, Mannucciy PM. Factor VII Clotting assay: influence of different thromboplastins and factor VH-deficient plasmas. Thromb Haemost 1991; 65: 160-164
• 29 Deijk WA, Dam-Mieras MCEvan, Muller D, Hemker HC. Evaluation of a coagulation assay determining the activity state of factor VII in plasma. Haemostasis 1983; 13: 192-197
• 30 Hemker HC, Muller AD, Gonggrijp R. The estimation of activated human blood coagulation factor VII. J Molecular Med 1976; 1: 127-134
• 31 Messmore HL, Koza M, Hoppensteadt D, Blakemore C, Walenga J. Results of factor VII assays in adults with vascular disease are dependent upon several variables. Thromb Haemost 1991; 65: 909
• 32 Østerud B. How to measure factor VII and factor VII activation. Haemostasis 1983; 13: 161-8
• 33 Carvalho de Sousa J, Soria C, Ayrault-Jarrier M. et al Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-944
• 34 Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J. Dietary changes in fasting levels of factor VII coagulant activity (FVILC)are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 1995; 73: 239-242
• 35 Miller GJ. Hyperlipidaemia and hypercoagulability. Prog Lipid Res 1993; 32: 61-69
• 36 Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541-549
• 37 Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14: 1737-1740
• 38 Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoproteins particles in middle aged men. Atherosclerosis 1989; 76: 203-208
• 39 Mitropoulos KA, Martin JC, Reeves BEA, Esnouf MP. The activation of the contact phase of coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles. Blood 1989; 73: 1525-1533
• 40 Mitropoulos KA, Reeves BEA, Miller GJ. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coagul Fibrinol 1993; 04: 943-951
• 41 Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor VII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis 1992; 95: 119-125
• 42 Marckmann P, Sandström B, Jespersen J. Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb 1992; 12: 201-205
• 43 Marckmann P, Sandström B, Jespersen J. Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-936
• 44 Miller GJ, Martin JC, Webster J. et al Association between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular mortality. Atherosclerosis 1986; 60: 269-77
• 45 Marckmann P, Sandström B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993; 13: 505-511
• 46 Brace LD, Gittler-Buffa C, Miller GJ. et al Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet. Arterioscler Thromb 1994; 14: 1282-1289
• 47 Pekkanen J, Mutanen M, Rasanen L, Rauramaa R, Nissinen A. Association of factor VIIc activity with dietary fat and blood lipids among elderly men - The Finnish cohorts of The Seven Countries Study. Nutr Metab Cardiovasc Dis 1995; 5: 149-54
• 48 Miller GJ, Stirling Y, Howarth DJ. et al Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 1995; 73: 893
• 49 Tholstrup T, Marckmann P, Jespersen J, Sandström B. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic or high in myristic and lauric acids. Am J Clin Nutr 1994; 59: 371-377
• 50 Foley M, Ball M, Chisholm A, Duncan A, Spears G, Mann J. Should mono- or poly-unsaturated fats replace saturated fat in the diet?. Eur J Clin Nutr 1992; 46: 429-436
• 51 Tholstrup T, Marckmann P, Jespersen J, Vessby B, Jart A, Sandström B. Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin Nutr 1994; 60: 919-925
• 52 Rankinen T, Rauramaa R, Väisänen S, Halonen P, Penttilä IM. Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise or fat modified diet. Fibrinolysis 1994; 8: 48-53
• 53 Hendra TJ, Britton ME, Roper DR. Effects of fish oil supplements in NIDDM subjects. Diabetes Care 1990; 13: 821-829
• 54 Shahar E, Folsom AR, Wu KK. et al Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. Arterioscler Thromb 1993; 13: 1205-1212
• 55 Schmidt EB, Lervang HH, Vanning K, Madsen P, Dyerberg J. Long-term supplementation with n-3 fatty acids. I: Effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Invest 1992; 53: 221-228
• 56 Marckmann P, Jespersen J, Leth T, Sandström B. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. JInt Med 1991; 229: 317-323
• 57 Lervang HH, Schmidt EB, Mpller J. et al The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease. Scand J Clin Lab Invest 1993; 53: 417-423
• 58 Muller AD, Houwelingen ACvan, Dam-Mieras MCEvan, Bas BM, Hornstra G. Effect of a moderate fish intake on haemostatic parameters in healthy males. Thromb Haemost 1989; 61: 468-473
• 59 Brown AJ, Roberts DCK. Fish and fish oil intake: effect on hematological variables related to cardiovascular disease. Thromb Res 1991; 64: 169-178
• 60 Berg-Schmidt E, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost 1990; 63: 1-5
• 61 Nordøy A, Hatcher L, Goodnight S, Fitzgerals GA, Connor WE. Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med 1994; 123: 914-920
• 62 Hornstra G. Effect of fish oil feeding on arterial trhombosis, platelet function and blood coagulation. In: Dietary Fats, Prostanods and arterial thrombosis Martinus Nijhoff Publishers; The Hague: 1982: 106-137
• 63 Marckmann P, Sandström S, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993; 102: 225-34
• 64 Bladbjerg EM, Marckmann P, Sandström B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755-788
• 65 Silveira A, Karpe F, Blombäcky M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60-69
• 66 Moor E, Hamsten A, Karpe F, Båvenholm P, Blombäck M, Silveira A. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age. Thromb Haemost 1994; 71: 707-712
• 67 Salomaa V, Rasi V, Pekkanen J. et al The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 1993; 103: 1-11
• 68 Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994; 14: 214-222
• 69 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. The Lancet 1993; 342: 1076-1079
• 70 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
• 71 Kario K, Matsuo T, Kario T, Kobayashi H. Sex-related differences in the relationship between plasma factor VII levels and serum lipids, lipoproteins and apolipoproteins. Thromb Res 1991; 64: 69-73
• 72 Tervahauta M, Pekkanen J, Kivinen P. et al Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries Study. Atherosclerosis 1993; 104: 47-59
• 73 Wright D, Poller L, Thomson JM, Gowland E, Burrows GE. The interrelationship of factor VII and its activity state with plasma lipids in healthy male adults. Br J Haematol 1993; 85: 348-351
• 74 Elwood PC, Beswick AD, O’Brien JR, Yamell JWG, Layzell JC, Limb ES. Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men. Blood Coagulat Fibrinol 1993; 4: 529-536
• 75 Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993; 99: 55-61
• 76 Marckmann P, SandstrÖm B, Jespersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992; 96: 235-244
• 77 Donders SHJ, Lustermans FAT, Wersch JWJvan. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest 1993; 53: 179-186
• 78 Donders SHJ, Lustermans FAT, Wersch JWJvan. Glycometabolic control, lipids, and coagulation parameters in patients with non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 1993; 23: 155-159
• 79 Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-270
• 80 Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21-27
• 81 Manolio TE, Ettinger WH, Tracy RP. et al Epidemiology of low cholesterol levels in older adults. Circulation 1993; 87: 728-737
• 82 Yang XC, Jing TY, Resnick LM, Phillips GB. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb 1993; 13: 467-471
• 83 Fredricksson DS, Levy RI, Lees RS. Fat transport in lipoproteins. An integrated approach to mechanisms and disorders. N Engl J Med 1967; 276: 94-103
• 84 Carvalho de Sousa J, Bruckert E, Giral P. et al Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyper-lipidaemia: A clinical and laboratory study. Haemostasis 1989; 19: 83-90
• 85 Avellone G, Garbo Vdi, Cordove R, Raneli G, Simone Rde, Bompiani GD. Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion. Blood Coagulation and Fibrinolysis 1993; 4: 429-433
• 86 Kario K, Matsuo T. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Atherosclerosis 1993; 103: 131-138
• 87 Nordøy A, Illingworh DR, Connor WE, Goodnight S. Increased activity of factor VII and factor Vll-phospholipid complex measured using a normo-test system in subjects with hyperlipidaemia. Haemostasis 1990; 20: 65-72
• 88 Saha N, Liu Y, Heng CK, Hong S, Low PS, sTay JSH. Association of factor VII genotype with plasma factor VII activityand antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscler Thromb 1994; 14: 1923-1927
• 89 Silveira A, Green F, Karpe F, Blomback M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 1994; 72: 734-739
• 90 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction betweenfactor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198
• 91 Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats ofthe w-6 and w-3 series reduce postprandial lipoprotein levels: chronicand acute effects of fat saturationon postprandial lipoprotein metabolism. J Clin Invest 1988; 82: 1884-1893
• 92 Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: Acritical review. J Lipid Res 1989; 30: 785-807